E-LIB Suche - Ergebnisse für: Hart, Lowell

1

Real-World Outcomes of Trilaciclib Among Patients with Exte..:

Goldschmidt, Jerome ; Hart, Lowell ; Scott, Jeffrey...
Advances in Therapy. 40 (2023) 10 - p. 4189-4215 , 2023

Link: https://doi.org/10.1007/..

2

A Phase Ib Study Assessing the Safety, Tolerability, and Ef..:

Bauer, Todd M. ; Moore, Kathleen N. ; Rader, Janet S....
Targeted Oncology. 18 (2023) 4 - p. 517-530 , 2023

Link: https://doi.org/10.1007/..

3

XENERA-1: a randomised double-blind Phase II trial of xentu..:

Schmid, Peter ; Cortes, Javier ; Joaquim, Ana...
Breast Cancer Research. 25 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

4

Burden of chemotherapy‐induced myelosuppression among patie..:

Hart, Lowell ; Ogbonnaya, Augustina ; Boykin, Kristen...
Cancer Medicine. 12 (2023) 8 - p. 10020-10030 , 2023

Link: https://doi.org/10.1002/..

5

Evaluation of Chemotherapy-Induced Myelosuppression in Pati..:

Hart, Lowell ; Ogbonnaya, Augustina ; Boykin, Kristen...
International Journal of Cancer Care and Delivery. 2 (2022) Supplement 2 - p. , 2022

Link: https://doi.org/10.53876..

6

Cardiac outcomes of subjects on adjuvant trastuzumab emtans..:

Barroso-Sousa, Romualdo ; Tarantino, Paolo ; Tayob, Nabihah...
npj Breast Cancer. 8 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

7

Circulating tumor cell number and endocrine therapy index i..:

Paoletti, Costanza ; Regan, Meredith M. ; Niman, Samuel M....
npj Breast Cancer. 7 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

8

Trilaciclib dose selection: an integrated pharmacokinetic a..:

Li, Chao ; Hart, Lowell ; Owonikoko, Taofeek K....
Cancer Chemotherapy and Pharmacology. 87 (2021) 5 - p. 689-700 , 2021

Link: https://doi.org/10.1007/..

9

Safety and impact of dose reductions on efficacy in the ran..:

Burris, Howard A. ; Chan, Arlene ; Bardia, Aditya...
British Journal of Cancer. 125 (2021) 5 - p. 679-686 , 2021

Link: https://doi.org/10.1038/..

10

A phase I/II study of the combination of panobinostat and c..:

Berdeja, Jesus G. ; Gregory, Tara K. ; Faber, Edward A....
American Journal of Hematology. 96 (2021) 4 - p. 428-435 , 2021

Link: https://doi.org/10.1002/..

11

Trilaciclib prior to chemotherapy and atezolizumab in patie..:

Daniel, Davey ; Kuchava, Vladimer ; Bondarenko, Igor...
International Journal of Cancer. 148 (2021) 10 - p. 2557-2570 , 2021

Link: https://doi.org/10.1002/..

12

The efficacy and safety of enzalutamide with trastuzumab in..:

Wardley, Andrew ; Cortes, Javier ; Provencher, Louise...
Breast Cancer Research and Treatment. 187 (2021) 1 - p. 155-165 , 2021

Link: https://doi.org/10.1007/..

13

Chemotherapy-related amenorrhea (CRA) after adjuvant ado-tr..:

Ruddy, Kathryn J. ; Zheng, Yue ; Tayob, Nabihah...
Breast Cancer Research and Treatment. 189 (2021) 1 - p. 103-110 , 2021

Link: https://doi.org/10.1007/..

14

Myelopreservation with Trilaciclib in Patients Receiving To..:

Hart, Lowell L. ; Ferrarotto, Renata ; Andric, Zoran G....
Advances in Therapy. 38 (2020) 1 - p. 350-365 , 2020

Link: https://doi.org/10.1007/..

15

Phase I study of imalumab (BAX69), a fully human recombinan..:

Mahalingam, Devalingam ; Patel, Manish R. ; Sachdev, Jasgit C....
British Journal of Clinical Pharmacology. 86 (2020) 9 - p. 1836-1848 , 2020

Link: https://doi.org/10.1111/..